fda1b59f4f2a124f17bdd68b231fe37c:96fa6eb3d4e6e1ac9fb94d78da6adbefd790494404d543ccbc06ad42f83135170ed945436cc42d9081f9c5250b7c615e16ef721a8502233935c9fd62347f9a35901d9f860f09c2194b8658e46cdd3db12420f9b1ffbb5e871888805bb3f78a721eb07266a60c9ea83302715217f06168caac06b35c48da83551519c6eb20656e3e35189e3138ba2353e8698ae9921d4f675a4bdcad205c62d6f70b14cbb5133101f8a318c47366ce20fa03a059d1fc9b8a714202e67fe918d12c43f905de7a85b8cbac82d4f826f023db9a02fe791f32db6b5efbac1bc9fd06c74c0c11fee2f47eddca5e8fa58103b965dbfb3e369d5a74f1282aaf50d00a9368f509d1ca1e45f6873bce62e8427d02457522526d3edb1a5c5ff1ef81f314be46ec4bb1b7c1b3a893d30f635cb9d3070f7ffe97aa2d8e6474b07fa4403dda9eda1512074fd048e1757015c3379c6a240368285702532f4a857f4b1b25c1a100aebfcd7227d92958e8255f41a64a9f0c37d7b8292e8e580b4d0697bfbbfd7be04db08e8c4c1bf2ecb79bc88200934eb931a4ef26a9e8e888e955e5b234e0f18eeaf716fd454e03